Seeka Limited — Director's Dealing 2021

Feb 15, 2021

==> picture [92 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		SeekaLimited
Date this disclosure made:		15-Feb-21
Date of last disclosure:		6-Oct-20

Director or senior manager giving disclosure

Director or senior managergiving disclosure
Full name(s):		FredAllan Hutchings
Name of listed issuer:		SeekaLimited
Name of related body corporate (if applicable):		NA
Position held in listed issuer:		Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:		Ordinary Shares
Nature of the affected relevant interest(s):		1) F A Hutchings has the power to exercise the right to voteattached to 20% or more of the voting rights of WalkerNominees Limited, resulting in F Hutchings having a relevantinterest in the Ordinary Shares of Seeka Limited held byWalker Nominees Limited.2) Seeka Share Trustee Limited holds Ordinary Shares inSeeka Limited for and on behalf of Amwell Holdings Limited.F Hutchings is a director of Amwell Holdings Limited. FHutchings is the registered holder of 26.24% of the shares inAmwell Holdings Limited in his personal capacity and aregistered holder of 58% of the shares in Amwell HoldingsLimited jointly with others. As such F Hutchings has thepower to control the exercise of 20% or more of the votingrights of Amwell Holdings Limited, resulting in F Hutchingshaving a relevant interest in the Ordinary Shares of SeekaLimited held by Seeka Share Trustee Limited for and onbehalf of Amwell Holdings Limited.3) Sharesies Nominee Limited holds Ordinary Shares inSeeka Limited for and on behalf of F A Hutchings
For that relevant interest-
Number held in class before acquisition or disposal:		1) 43,421 Ordinary Shares2) 2,463 Ordinary Shares3)2,501 OrdinaryShares
Number held in class after acquisition or disposal:		1) 44,450 Ordinary Shares2) 2,463 Ordinary Shares3)2,501 OrdinaryShares
Current registered holder(s):		1) NA2) NA3)NA
Registered holder(s) once transfers are registered:		1) Walker Nominees Limited2) Seeka Share Trustee Limited for and on behalf of AmwellHoldings Limited.2)Sharesies Nominee Limited on behalf of F A Hutchings

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

		e)
		NA
		NA
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):		NA
A statement as to whether the derivative is cash settled orphysicallysettled:		NA
Maturitydate of the derivative(if any):		NA
Expirydate of the derivative(if any):		NA
Theprice specified in the terms of the derivative(if any):		NA
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products:		NA
_For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:
Parties to the derivative:		NA
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:		NA

Details of transactions giving rise to acquisition or disposal

Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
Details of transactions requiring disclosure-
Date oftransaction:		Transaction 27 January2021
		Allotment pursuant to Seeka Limited's Dividend
Nature of transaction:		Reinvestment Plan
Name ofany otherparty orparties to the transaction(if known):		NA
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:		$4,849.06(1,029 OrdinaryShares at$4.7124 each)
Numberof financialproducts towhichthe transaction related:		1,029 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:		NA
Date of the prior written clearance (if any):		NA

Summary of other relevant interests after acquisition or disposal:

Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:		NA
Nature of relevantinterest:		NA
_For that relevant interest,- _
Number heldinclass:		NA
Currentregisteredholder(s):		NA
For a derivative relevant interest,-
Type ofderivative:		NA
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any):		NA
A statement as to whether the derivative is cash settled or physically settled:		NA
Maturity date of the derivative (if any):		NA
Expiry date of the derivative (if any):		NA
The price's specified terms (if any):		NA
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying		NA
financialproducts:
For that derivative relevant interest,-		NA
Parties to the derivative:		NA
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:		NA

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

F A Hutchings 15-Feb-21 S MCKinstry 15-Feb-21 S McKinstry - CFO

Notes

Use this form to disclose all the acquisitions and disposals by a director or senior manager of a listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be made within—

(a) 20 working days after the first acquisition or disposal disclosed in this notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets Conduct Act 2013; or

(b) in any other case, 5 trading days after the first acquisition or disposal disclosed in this notice.